The observed incidence of anaphylaxis and serum sickness in patients receiving omalizumab in a tertiary allergy and asthma clinic in Canada

相似書籍

• Xolair® (omalizumab) enrollment in a tertiary care allergy and asthma clinic in Canada
  由: Cameron, Jodi, et al.
  出版: (2014)
• Seminal fluid anaphylaxis
  由: Deria, Mariam, et al.
  出版: (2011)
• Use of Omalizumab to treat a nine-year old, with steroid-dependent, allergic asthma, adrenal insufficiency and vertebral compression fractures due to steroid induced severe osteoporosis
  由: Ring, Alicia, et al.
  出版: (2011)
• Real-World Observational Study on the Characteristics and Treatment Patterns of Allergic Asthma Patients Receiving Omalizumab in Canada
  由: Lee, Jason K, et al.
  出版: (2020)
• Omalizumab treatment of moderate to severe asthma in the adolescent and pediatric population
  由: O’Quinn, John, et al.
  出版: (2014)